SCHEDULE 13G/A: Armistice Capital Discloses Near 10% Stake in Wearable Devices Ltd.
Beneficial Ownership Report
Armistice Capital, LLC and Steven Boyd have filed an amended Schedule 13G, revealing a 9.99% beneficial ownership stake in Wearable Devices Ltd.'s Ordinary Shares as of March 31, 2025.
Summary
- Armistice Capital, LLC and Steven Boyd (collectively, the "Reporting Persons") have filed an Amendment No. 1 to Schedule 13G regarding their beneficial ownership in Wearable Devices Ltd.
- As of March 31, 2025, the Reporting Persons collectively beneficially own 73,342 Ordinary Shares of Wearable Devices Ltd.
- This ownership represents 9.99% of the total outstanding Ordinary Shares of Wearable Devices Ltd.
- Armistice Capital, LLC, a Delaware entity, serves as the investment manager for Armistice Capital Master Fund Ltd., which is the direct holder of the shares.
- Steven Boyd, a U.S. citizen, is the managing member of Armistice Capital, LLC.
- The filing indicates that the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that inherently indicates positive or negative sentiment regarding the company's performance or outlook.
Future Outlook
NA
Industry Context
This filing is a standard disclosure of a significant ownership stake by an institutional investor in a publicly traded company, common across various industries.
Stakeholder Impact
- Shareholders: The disclosure of a significant 9.99% stake by an institutional investor like Armistice Capital could be viewed as a vote of confidence or simply a factual update on the company's ownership structure. It indicates a large block of shares is held by a single entity, which can influence trading dynamics.
Key Dates
| Date | Description |
|---|---|
| 03/31/2025 | Date of event which required the filing of this statement (beneficial ownership threshold met or changed). |
| 05/15/2025 | Date the Schedule 13G/A filing was signed and submitted. |
Keywords
Wearable Devices Ltd., Armistice Capital, Steven Boyd, Schedule 13G, Beneficial Ownership, SEC Filing, Ordinary Shares, Institutional Investor
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.